There were 1,763 press releases posted in the last 24 hours and 426,773 in the last 365 days.

Clear Health Pass™ Launches Revolutionary COVID Pet Test™ at VMX

A look at the Test

A look at the results

Protecting Our Furry Companions at the 40th Annual Veterinary Meeting & Expo (VMX)

In 2023, we estimate that 76 million US pet owners will be infected with COVID-19, making the COVID Pet Test™ a vital tool in the fight against COVID-19”
— John Cataldi, CEO of Clear Health Pass™
ORLANDO, FL, USA, January 17, 2023 /EINPresswire.com/ -- Clear Health Pass™ is excited to announce the launch of its revolutionary COVID Pet Test™ at the 40th Annual Veterinary Meeting & Expo (VMX). Recognizing the importance of keeping our furry companions safe, the company has developed a test specifically for dogs and cats that will be available throughout the United States, where an estimated 85 million cats and 78 million dogs reside.

“With 68% of US households having pets, the demand for this innovative test is clear. In 2023, we estimate that 76 million US pet owners will be infected with COVID-19, making the COVID Pet Test™ a vital tool in the fight against COVID-19. We look forward to working with the veterinary community in our efforts further to develop our research on COVID-19 and our beloved pets," says John-Michael Cataldi, CEO of Clear Health Pass™.

The COVID Pet Test™ is simple and easy to use. A veterinarian provides the test to the pet owner. The pet owner registers their collection kit via a QR code on their computer or mobile device. During a morning walk, the pet owner will collect a fecal sample using the COVID Pet Test’s™ collection device and place it in a FedEx priority overnight shipping PAK. The sample goes directly to the Lab, where it gets tested via PCR (the gold standard of COVID-19 Testing). Results are sent to the veterinarian and the pet owner via SMS and web application within 48 hours. In the event of a positive test result, the Vet and pet owner will be notified and provided with additional information based on FDA and CDC guidelines concerning infectious controls.

Clear Health Pass™ has partnered with Premiere Medical Lab Network in the development of the COVID Pet Test™. The lab network is a Certified High Complexity, CLIA, and CAP Accredited Lab. The COVID Pet Test™ was specifically developed to target Canine and Feline infections via qualitative detection of nucleic acids from the SARS-CoV-2. The COVID Pet Test™ uses a proprietary Pet Fecal COVID-19 Assay that allows rapid and reliable isolation of high-quality total RNA from fresh pet stool samples assay utilizes a multiplex real-time reverse transcription polymerase chain reaction (RT-PCR).

About Clear Health Pass™ / COVID Pet Test™

Clear Health Pass™ is a bioinformatics, bio-surveillance, and health diagnostic platform for humans and Pets. Clear Health Pass™ is a minority/veteran-operated organization in partnership as tribal is a portfolio partner of The Native American Venture Fund (NAVF). Clear Health Pass Holdings, LLC, DBA Clear Health Pass™ is an appointed “Tribal Agent” for The Blue Lake Rancheria Economic Development Corporation (BLREDC), a federal, Section 17 Tribal Corporation, whose tribal sovereignty’s authority is derived from The Indian Reorganization Act Of 1934 (IRA), 25 U.S.C. § 477. The COVID Pet Test™ (Patent Pending) is an FDA-registered medical Device by Clear Health Pass™. All testing of the Pet COVID Pet Test™ utilizing (CHP) proprietary kit & assay(s) is performed by Premiere Labs, a Certified, High Complexity, CLIA, and CAP Accredited Lab.
www.ClearHealthPass.com
www.CovidPetTests.com

Silvia Bronder, COO
Clear Health Pass™
+1 305-321-1919
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Instagram
YouTube

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.